View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Talimogen Laherparepvec 100, Malignant Melanoma, Cycle 2+
Protocol-ID: 1184 V1.0 (Mini), T-VEC100, Melanoma, C2+Indication(s)
- Melanoma, Malignant; ICD-10 C44.-
Links
- Cutaneous Melanoma: ESMO Clinical Practice Guidelines 09/2015 [ESMO]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.04.2019